<DOC>
	<DOCNO>NCT00834652</DOCNO>
	<brief_summary>This study determine whether drug metformin improve effect traditional antidepressant medication people overweight .</brief_summary>
	<brief_title>Adding Insulin-Sensitizing Medication Depression Treatment People Who Are Depressed Overweight</brief_title>
	<detailed_description>Current depression treatment effective approximately one-half overweight people , depression eventually return approximately one-third overweight people whose initial treatment effective . One possible reason treatment failure overweight people often experience condition call insulin resistance ( IR ) , lead type 2 diabetes , associate disease might also affect depression treatment . IR result elevate blood sugar level may interfere medication use treat depression . Metformin , medication commonly use treat diabetes , reduces blood sugar level . This study examine whether take metformin antidepressant medication sertraline enhance effectiveness sertraline people overweight depress . Participation study divide two phase last total 40 week . Phase 1 last 16 week include baseline test seven schedule study visit . During phase , participant randomly assign receive either sertraline metformin sertraline placebo daily basis . The baseline visit include follow test measure : electrocardiogram ( EKG ) , measure electrical activity heart ; oral glucose tolerance test ( OGTT ) , measure person 's body break glucose ; blood test , measure lipid , hemoglobin A1C , cardiometabolic risk factor ; dual energy x-ray absorptimetry ( DEXA ) scan , measure body fat ; pregnancy test woman ; measurement vital sign , height , weight , waist-to-hip ratio , waist circumference ; questionnaires concern health , medication use , physical activity , diet , mood . Some questionnaire administer interview researcher . During study visit , occur every 2 week , participant complete questionnaire , unused medication collect , new medication hand . At Week 8 , participant provide additional blood sample finger stick . At end Phase 1 , participant undergo repeat baseline test . Participants whose depression improve Phase 1 eligible continue Phase 2 study , determine long term effect take metformin sertraline . Phase 2 study last 24 week , study visit occur monthly . During study visit , participant complete questionnaire , medication collect hand . At Weeks 24 32 , participant provide blood sample finger stick . After complete Phase 2 , participant undergo repeat baseline testing .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Body mass index ( BMI ) great 28.7 Positive screen depression Must live within 100 mile St. Louis metropolitan area Pregnant breastfeeding Known hypersensitivity sertraline metformin Recent history heart attack unstable heart disease Severe liver disease kidney impairment , define serum creatine level 3 mg/dL Psychiatric disorder think affect management , schizophrenia , alcohol drug dependence</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Metabolic Diseases</keyword>
	<keyword>Depressive Disorder , Major</keyword>
	<keyword>Depressive Disorder</keyword>
	<keyword>Glucose Metabolism Disorders</keyword>
	<keyword>Depression Recurrence</keyword>
</DOC>